These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12227188)

  • 21. Differential development of 5-HT receptor and the serotonin transporter binding in the human infant medulla.
    Paterson DS; Belliveau RA; Trachtenberg F; Kinney HC
    J Comp Neurol; 2004 Apr; 472(2):221-31. PubMed ID: 15048689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
    Zhou D; Harrison BL; Shah U; Andree TH; Hornby GA; Scerni R; Schechter LE; Smith DL; Sullivan KM; Mewshaw RE
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1338-41. PubMed ID: 16332439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters.
    Zhang S; Zhen J; Reith ME; Dutta AK
    Bioorg Med Chem; 2004 Dec; 12(23):6301-15. PubMed ID: 15519172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors.
    Mannoury la Cour C; Hanoun N; Melfort M; Hen R; Lesch KP; Hamon M; Lanfumey L
    J Neurochem; 2004 May; 89(4):886-96. PubMed ID: 15140188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors.
    Meagher KL; Mewshaw RE; Evrard DA; Zhou P; Smith DL; Scerni R; Spangler T; Abulhawa S; Shi X; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1885-8. PubMed ID: 11459653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
    Adrien J
    J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.
    Ryckmans T; Berton O; Grimée R; Kogej T; Lamberty Y; Pasau P; Talaga P; Genicot C
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3195-8. PubMed ID: 12372532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
    Pullar IA; Carney SL; Colvin EM; Lucaites VL; Nelson DL; Wedley S
    Eur J Pharmacol; 2000 Oct; 407(1-2):39-46. PubMed ID: 11050288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.
    Barkan T; Gurwitz D; Levy G; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2004 May; 14(3):237-43. PubMed ID: 15056483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance.
    Richelson E
    J Clin Psychiatry; 2003; 64 Suppl 13():5-12. PubMed ID: 14552650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism.
    Oficialdegui AM; Martinez J; Pérez S; Heras B; Irurzun M; Palop JA; Tordera R; Lasheras B; del Río J; Monge A
    Farmaco; 2000 May; 55(5):345-53. PubMed ID: 10983279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serotonin receptor and transporter as potential therapeutic targets for pulmonary hypertension.
    Wang HL
    Curr Opin Investig Drugs; 2004 Sep; 5(9):963-6. PubMed ID: 15503652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.